Navigation Links
The Hidden Crisis: Commercial Sexual Exploitation of Girls
Date:10/21/2008

YWCA, which has affiliates in 122 countries that serve 25 million women and girls worldwide. For more information, visit http://www.ywca.org. Contact: Nancy Loving, Communications Director, at 202-467-0801 or nloving@ywca.org. YWCA USA, 1015 - 18th Street, NW, Suite 1100, Washington, DC 20036.

Women's Policy, Inc. (WPI) is a nonprofit, nonpartisan organization whose sole focus is to help ensure that the most informed decisions on key women's issues are made by policymakers at the federal, state, and local levels. For more information, visit http://www.womenspolicy.org. Contact: Cindy Hall, President, 202-554-2323 or cindy@womenspolicy.org. Women's Policy, Inc. 409 12th Street, SW, Suite 310, Washington, DC 20024.

(1) Estes & Weiner. The commercial sexual exploitation of children in the U.S., Canada and Mexico. University of Pennsylvania School of Social Work, 2001. http://www.sp2.upenn.edu/~restes/CSEC_Files/Exec_Sum_020220.pdf


'/>"/>
SOURCE YWCA USA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
2. Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer
3. Vanda Pharmaceuticals to Present at Natixis Bleichroeders Hidden Gems Conference
4. National Geographic Channel, Ashley Judd and YouthAIDS Host World Premiere Screening of Indias Hidden Plague
5. Video Pill Spots Hidden Crohns Disease
6. California Wildfires - The Hidden Dangers & Actions You Can Take
7. Brain MRIs Find Hidden Neurological Problems
8. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
9. Protect Pets From Winters Hidden Dangers
10. Hidden Veggies on the go hits Whole Foods Market(R) in 2008
11. Routine screenings uncover hidden carbon monoxide poisoning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...olesterol-lowering drugs known as statins are amon...new study by researchers at Fred Hutchinson Cancer...t stem cell transplant patients from one of the mo... therapy: graft-versus-host disease, or GVHD. The ...of the journal Blood . , In a retrospective stud...
(Date:12/4/2009)...ledge of risks, many hesitate to take breast cance...HealthDay News) -- Worries about side effects are ...n at high risk for breast cancer are willing to ta...w study finds. , In an effort to inform women a...ers at the University of Michigan Comprehensive Ca...
(Date:12/4/2009)... TrekDesk Inventor Showcasing Innovative... (Vocus) December 4, 2009 -- A valley invent...proven to help individuals lose weight, prevent di...uctivity will be showcasing the product at Saturda...ter Gallery., , , , , TrekDesk has been featured...
(Date:12/4/2009)..., JACKSONVILLE, Fla., Dec. 4 Tod...rds for their work in improving the health of Flor...tion for a Healthy Florida,s 2009 Sapphire Award c...y statewide award that recognizes and promotes org...dressing health disparities within their communiti...
(Date:12/4/2009)...SHINGTON, Dec. 4 As Con...lan, Family Research Council (FRC) today announced...es in Louisiana to survey each household on provis...e abortion funding, rationing, higher taxes, and g...Survey participants who express opposition to the ...
Breaking Medicine News(10 mins):Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2
...d on findings of a recent study researchers say an...have little effect on // hospitalizations, respira...The finding was especially true for children who r...ected. However, for children under age 2 who recei...
...rding to a recent study researchers say, Monteluka...s mediate inflammation // in the body and play a r... asthma in young children by about 32 percent whil... of the children received low-dose montelukast onc...
...icosteroids, which are routinely used to treat pat...to death, //reports a study conducted at London Sc...esearchers had studied the effect of this drug on ...s. The results showed that there seems to be an in...
...rding to a recent study researchers say those in t...e associated with // an increased risk of suicidal...ents with depression and other clinical conditions...atients taking SSRIs and those taking other drugs,...
...ford Hospital in US is one of the first to impleme...ings of the heart without having to operate.// The... of the patient’s heart. The technology uses an “i... preferences to cardiac surgeons even before they ...
...nt studies have shown that oral examination may no...urbances in patients.// Earlier patients suffe...have mostly been related to snoring in their sleep..., heart problems, stroke, and obesity, breathing p...
Other Medicine News:
(Date:12/4/2009)..., SAN DIEGO, Calif., Dec. 4 Sune...ice company, today announced the appointment of Ph...Officer. In this role, Mr. Ranker will lead all S...ns including finance, accounting, IT, IR, administ... the Company,s senior management team. ,, "One...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 Drs. Neal... prostate-specific antigen (PSA) recurrence from t...biochemical recurrence rate in a Phase III pivotal...jection) or monthly leuprolide in prostate cancer ...tate cancer patients who received FIRMAGON 240/80 ...
(Date:12/3/2009)..., ACTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -...Holdings, Inc. (NYSE: HRC ), today announced the... Equipment Manufacturer) business website www.Al...e Allen Amatech(TM) brand identity and includes an...etailed descriptions and design specifications for...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 1Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 2Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 1Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 2Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 32009 India Excellence in Healthcare Awards 56519 12009 India Excellence in Healthcare Awards 56519 22009 India Excellence in Healthcare Awards 56519 32009 India Excellence in Healthcare Awards 56519 4
...if., Jan. 9 Rigel,Pharmaceuticals, Inc. (Nasdaq: ...g patients in a Phase 1 study to evaluate the safe...potent inhibitor of Janus Kinase,3 (JAK3), as a po...hritis,(RA), psoriasis and other immune disorders....ctive in reducing arthritic symptoms, bone destruc...
...mafore Pharmaceuticals Inc.,today announced that a...,Issue 1: 206-215) reports that SF1126, the compan... antiangiogenic activity., The paper, entitled "A...nhibitor Prodrug, SF1126, with Antitumor and Antia...es conducted by Semafore and collaborators at,Chil...
Other Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 2Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 3Semafore's SF1126 Exhibits Antitumor and Antiangiogenic Activity 2
Sundt Slim-Line Temporary Aneurysm Clip
Micro Needle Holders With Lock
Vascular Clamps B-3
Rhoton #12 Straight Point Needle
Medicine Products: